Rankings
▼
Calendar
TECX Q2 2018 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena
TECX
Tectonic Therapeutic, Inc.
$634M
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$45,000
Operating Income
-$10M
Net Income
-$11M
EPS (Diluted)
$-5.29
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$159M
Total Liabilities
$10M
Stockholders' Equity
$148M
Cash & Equivalents
$155M
← FY 2018
All Quarters
Q3 2018 →